Carbamazepine attenuates inducible nitric oxide synthase expression through Akt inhibition in activated microglial cells

Chen Hsu Wang, Che Jen Hsiao, Yi Nung Lin, Joe Wei Wu, Yu Cheng Kuo, Ching Kuo Lee, George Hsiao

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Carbamazepine, which was developed primarily for the treatment of epilepsy, is now also useful for the treatment of non-epileptic disorders and inflammatory hyperalgesia. However, the mechanism of its anti-neuroinflammatory action remains poorly understood.

Objective: This study elucidates the anti-neuroinflammatory capacity of carbamazepine on microglial activation and the relative mechanisms involved.

Materials and methods: The microglial BV-2 cells were pretreated with carbamazepine for 15min before activation by lipopolysaccharide (LPS). After LPS stimulation, the expression of inducible nitric oxide synthase (iNOS) was analyzed by Western blotting (WB) and reverse transcription-polymerase chain reaction. Signaling proteins and cyclooxygenase (COX)-2 were also evaluated by WB. The levels of nitrate and tumor necrosis factor (TNF)-α were analyzed by the Griess method and enzyme-linked immunosorbant assay, respectively. The formation of intracellular reactive oxygen species (ROS) was examined by fluorescent analysis.

Results: Carbamazepine strongly attenuated LPS-induced production of NO and iNOS protein at concentrations of 5, 10, and 20μM. Consistently, it could markedly suppress iNOS mRNA expression stimulated by LPS. Among the signaling pathways, LPS-mediated IκBα degradation or JNK MAPK phosphorylation was not affected by carbamazepine. Interestingly, it was found that carbamazepine could concentration-dependently inhibit LPS-Activated phospho-Akt expression. Nevertheless, LPS-induced ROS production was not affected by carbamazepine. Carbamazepine (20μM) affected either COX-2 expression or TNF-α production induced by LPS with approximately 70% and 51% inhibition, respectively.

Discussion and conclusion: Our findings showed that carbamazepine exerted selective inhibition on LPS-induced microglial iNOS expression through the down-regulation of Akt activation, and thus may play a pivotal role of anti-neuroinflammation in its therapeutic efficacy.

Original languageEnglish
Pages (from-to)1451-1459
Number of pages9
JournalPharmaceutical Biology
Volume52
Issue number11
DOIs
Publication statusPublished - Nov 1 2014

Fingerprint

Carbamazepine
Nitric Oxide Synthase Type II
Lipopolysaccharides
Cyclooxygenase 2
Reactive Oxygen Species
Tumor Necrosis Factor-alpha
Western Blotting
Hyperalgesia
Nitrates
Reverse Transcription
Epilepsy
Proteins
Down-Regulation
Phosphorylation
Polymerase Chain Reaction
Messenger RNA
Enzymes

Keywords

  • INOS
  • LPS
  • Microglia

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Pharmaceutical Science
  • Complementary and alternative medicine
  • Molecular Medicine
  • Medicine(all)

Cite this

Carbamazepine attenuates inducible nitric oxide synthase expression through Akt inhibition in activated microglial cells. / Wang, Chen Hsu; Hsiao, Che Jen; Lin, Yi Nung; Wu, Joe Wei; Kuo, Yu Cheng; Lee, Ching Kuo; Hsiao, George.

In: Pharmaceutical Biology, Vol. 52, No. 11, 01.11.2014, p. 1451-1459.

Research output: Contribution to journalArticle

Wang, Chen Hsu ; Hsiao, Che Jen ; Lin, Yi Nung ; Wu, Joe Wei ; Kuo, Yu Cheng ; Lee, Ching Kuo ; Hsiao, George. / Carbamazepine attenuates inducible nitric oxide synthase expression through Akt inhibition in activated microglial cells. In: Pharmaceutical Biology. 2014 ; Vol. 52, No. 11. pp. 1451-1459.
@article{c80ecb36849e4af1890160abe98dcbc7,
title = "Carbamazepine attenuates inducible nitric oxide synthase expression through Akt inhibition in activated microglial cells",
abstract = "Background: Carbamazepine, which was developed primarily for the treatment of epilepsy, is now also useful for the treatment of non-epileptic disorders and inflammatory hyperalgesia. However, the mechanism of its anti-neuroinflammatory action remains poorly understood.Objective: This study elucidates the anti-neuroinflammatory capacity of carbamazepine on microglial activation and the relative mechanisms involved.Materials and methods: The microglial BV-2 cells were pretreated with carbamazepine for 15min before activation by lipopolysaccharide (LPS). After LPS stimulation, the expression of inducible nitric oxide synthase (iNOS) was analyzed by Western blotting (WB) and reverse transcription-polymerase chain reaction. Signaling proteins and cyclooxygenase (COX)-2 were also evaluated by WB. The levels of nitrate and tumor necrosis factor (TNF)-α were analyzed by the Griess method and enzyme-linked immunosorbant assay, respectively. The formation of intracellular reactive oxygen species (ROS) was examined by fluorescent analysis.Results: Carbamazepine strongly attenuated LPS-induced production of NO and iNOS protein at concentrations of 5, 10, and 20μM. Consistently, it could markedly suppress iNOS mRNA expression stimulated by LPS. Among the signaling pathways, LPS-mediated IκBα degradation or JNK MAPK phosphorylation was not affected by carbamazepine. Interestingly, it was found that carbamazepine could concentration-dependently inhibit LPS-Activated phospho-Akt expression. Nevertheless, LPS-induced ROS production was not affected by carbamazepine. Carbamazepine (20μM) affected either COX-2 expression or TNF-α production induced by LPS with approximately 70{\%} and 51{\%} inhibition, respectively.Discussion and conclusion: Our findings showed that carbamazepine exerted selective inhibition on LPS-induced microglial iNOS expression through the down-regulation of Akt activation, and thus may play a pivotal role of anti-neuroinflammation in its therapeutic efficacy.",
keywords = "INOS, LPS, Microglia",
author = "Wang, {Chen Hsu} and Hsiao, {Che Jen} and Lin, {Yi Nung} and Wu, {Joe Wei} and Kuo, {Yu Cheng} and Lee, {Ching Kuo} and George Hsiao",
year = "2014",
month = "11",
day = "1",
doi = "10.3109/13880209.2014.898074",
language = "English",
volume = "52",
pages = "1451--1459",
journal = "Pharmaceutical Biology",
issn = "1388-0209",
publisher = "Informa Healthcare",
number = "11",

}

TY - JOUR

T1 - Carbamazepine attenuates inducible nitric oxide synthase expression through Akt inhibition in activated microglial cells

AU - Wang, Chen Hsu

AU - Hsiao, Che Jen

AU - Lin, Yi Nung

AU - Wu, Joe Wei

AU - Kuo, Yu Cheng

AU - Lee, Ching Kuo

AU - Hsiao, George

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Background: Carbamazepine, which was developed primarily for the treatment of epilepsy, is now also useful for the treatment of non-epileptic disorders and inflammatory hyperalgesia. However, the mechanism of its anti-neuroinflammatory action remains poorly understood.Objective: This study elucidates the anti-neuroinflammatory capacity of carbamazepine on microglial activation and the relative mechanisms involved.Materials and methods: The microglial BV-2 cells were pretreated with carbamazepine for 15min before activation by lipopolysaccharide (LPS). After LPS stimulation, the expression of inducible nitric oxide synthase (iNOS) was analyzed by Western blotting (WB) and reverse transcription-polymerase chain reaction. Signaling proteins and cyclooxygenase (COX)-2 were also evaluated by WB. The levels of nitrate and tumor necrosis factor (TNF)-α were analyzed by the Griess method and enzyme-linked immunosorbant assay, respectively. The formation of intracellular reactive oxygen species (ROS) was examined by fluorescent analysis.Results: Carbamazepine strongly attenuated LPS-induced production of NO and iNOS protein at concentrations of 5, 10, and 20μM. Consistently, it could markedly suppress iNOS mRNA expression stimulated by LPS. Among the signaling pathways, LPS-mediated IκBα degradation or JNK MAPK phosphorylation was not affected by carbamazepine. Interestingly, it was found that carbamazepine could concentration-dependently inhibit LPS-Activated phospho-Akt expression. Nevertheless, LPS-induced ROS production was not affected by carbamazepine. Carbamazepine (20μM) affected either COX-2 expression or TNF-α production induced by LPS with approximately 70% and 51% inhibition, respectively.Discussion and conclusion: Our findings showed that carbamazepine exerted selective inhibition on LPS-induced microglial iNOS expression through the down-regulation of Akt activation, and thus may play a pivotal role of anti-neuroinflammation in its therapeutic efficacy.

AB - Background: Carbamazepine, which was developed primarily for the treatment of epilepsy, is now also useful for the treatment of non-epileptic disorders and inflammatory hyperalgesia. However, the mechanism of its anti-neuroinflammatory action remains poorly understood.Objective: This study elucidates the anti-neuroinflammatory capacity of carbamazepine on microglial activation and the relative mechanisms involved.Materials and methods: The microglial BV-2 cells were pretreated with carbamazepine for 15min before activation by lipopolysaccharide (LPS). After LPS stimulation, the expression of inducible nitric oxide synthase (iNOS) was analyzed by Western blotting (WB) and reverse transcription-polymerase chain reaction. Signaling proteins and cyclooxygenase (COX)-2 were also evaluated by WB. The levels of nitrate and tumor necrosis factor (TNF)-α were analyzed by the Griess method and enzyme-linked immunosorbant assay, respectively. The formation of intracellular reactive oxygen species (ROS) was examined by fluorescent analysis.Results: Carbamazepine strongly attenuated LPS-induced production of NO and iNOS protein at concentrations of 5, 10, and 20μM. Consistently, it could markedly suppress iNOS mRNA expression stimulated by LPS. Among the signaling pathways, LPS-mediated IκBα degradation or JNK MAPK phosphorylation was not affected by carbamazepine. Interestingly, it was found that carbamazepine could concentration-dependently inhibit LPS-Activated phospho-Akt expression. Nevertheless, LPS-induced ROS production was not affected by carbamazepine. Carbamazepine (20μM) affected either COX-2 expression or TNF-α production induced by LPS with approximately 70% and 51% inhibition, respectively.Discussion and conclusion: Our findings showed that carbamazepine exerted selective inhibition on LPS-induced microglial iNOS expression through the down-regulation of Akt activation, and thus may play a pivotal role of anti-neuroinflammation in its therapeutic efficacy.

KW - INOS

KW - LPS

KW - Microglia

UR - http://www.scopus.com/inward/record.url?scp=84912136975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912136975&partnerID=8YFLogxK

U2 - 10.3109/13880209.2014.898074

DO - 10.3109/13880209.2014.898074

M3 - Article

C2 - 25026355

AN - SCOPUS:84912136975

VL - 52

SP - 1451

EP - 1459

JO - Pharmaceutical Biology

JF - Pharmaceutical Biology

SN - 1388-0209

IS - 11

ER -